1-3 of 3
Michael Volk
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Durable Remissions with the VcR-CVAD Regimen for Mantle Cell Lymphoma (MCL), Regardless of Age: Long-Term Follow-up of a Wisconsin Oncology Network (WON) Study

Julie E. Chang, MD, Christopher Peterson, MD, Lakeesha L. Carmichael, MS, KyungMann Kim, PhD, David T. Yang, MD, Anne M. Traynor, MD, Jae E. Werndli, BSc, MSc, Michael Huie, MD, Thomas McFarland, MD, Michael Volk, MD, Jules H. Blank, MD, Natalie S. Callander, MD, Walter L. Longo, MD, Brad S. Kahl, MD
Journal: Blood
Blood (2016) 128 (22): 149.
https://doi.org/10.1182/blood.V128.22.149.149
Published: 2016
Journal Articles

Bendamustine + Rituximab (BR) Chemoimmunotherapy and Maintenance Lenalidomide in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Wisconsin Oncology Network (WON) Study

Julie E. Chang, MD, Chong Zhang, KyungMann Kim, PhD, Rachel Kirby, Lynn Volk, Jae Werndli, Ronald S. Go, MD, Matthias Weiss, MD, PhD, Jules H. Blank, MD, Michael A. Thompson, MD, PhD, John P. Farnen, MD, FACP, Craig E. Cole, MD, Ali W. Bseiso, MBBS, Michael Volk, MD, Gerald Bayer, MD, Tim Wassenaar, MD, Patrick Mansky, MD, Anne Traynor, Timothy S. Fenske, MD, Brad S. Kahl, M.D.
Journal: Blood
Blood (2012) 120 (21): 3647.
https://doi.org/10.1182/blood.V120.21.3647.3647
Published: 2012
Journal Articles

VcR-CVAD Produces a High Complete Response Rate in Untreated Mantle Cell Lymphoma: A Phase II Study from the Wisconsin Oncology Network

Brad Kahl, Julie Chang, Jens Eickhoff, Leslie Gilbert, Eric Rogers, Jae Werndli, Michael Huie, Thomas McFarland, Michael Volk, Jules H. Blank, Natalie Callander, Walter Longo, Christopher Peterson
Journal: Blood
Blood (2008) 112 (11): 265.
https://doi.org/10.1182/blood.V112.11.265.265
Published: 2008